Drug Type Small molecule drug |
Synonyms- |
Action inhibitors, antagonists |
Mechanism EGFR T790M inhibitors(Epidermal Growth Factor Receptor T790M inhibitors), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | - | 01 Aug 2025 |





